Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2023 Filed Mar 4, 2023 00:00 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 1,576 | $22.75 | $35,854.00 |
DisclosureSEC source: 0001437749-23-005438 · rdgdoc.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,253 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 01, 2023 Filed Jun 23, 2023 23:33 UTC |
Phillips GeraintSVP, Global Operations
|
SaleCommon Stock | 844 | $22.75 | $19,201.00 |
DisclosureSEC source: 0001437749-23-018321 · rdgdoc.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,607 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 00:00 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 117 | $21.47 | $2,511.99 |
DisclosureSEC source: 0001437749-23-004430 · rdgdoc.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,829 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 21, 2023 Filed Jun 23, 2023 23:34 UTC |
Phillips GeraintSVP, Global Operations
|
SaleCommon Stock | 133 | $21.47 | $2,855.51 |
DisclosureSEC source: 0001437749-23-018322 · rdgdoc.xml · nonDerivative · entry 1 Phillips Geraint · CIK 0001960665 · SVP, Global Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,451 F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 09, 2023 Filed Feb 14, 2023 00:01 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 78 | $24.60 | $1,918.80 |
DisclosureSEC source: 0001437749-23-003208 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,687 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 09, 2023 Filed Feb 14, 2023 00:01 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 81 | $24.60 | $1,992.60 |
DisclosureSEC source: 0001437749-23-003207 · rdgdoc.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,708 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 09, 2023 Filed Feb 14, 2023 00:01 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 144 | $24.60 | $3,542.40 |
DisclosureSEC source: 0001437749-23-003205 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456,469 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 09, 2023 Filed Feb 14, 2023 00:01 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 56 | $24.60 | $1,377.60 |
DisclosureSEC source: 0001437749-23-003206 · rdgdoc.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,381 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 09, 2023 Filed Feb 14, 2023 00:00 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 55 | $24.60 | $1,353.00 |
DisclosureSEC source: 0001437749-23-003204 · rdgdoc.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,112 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 09, 2023 Filed Feb 14, 2023 00:00 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 58 | $24.60 | $1,426.80 |
DisclosureSEC source: 0001437749-23-003203 · rdgdoc.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,207 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 00:01 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-23-002930 · rdgdoc.xml · derivative · entry 6 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 9,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Exercisable to the extent of 1/4th thereof on 5/4/16, and remaining balance exercisable to the extent of 1/36th thereof on the 4th day of each month commencing on 6/4/16. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 00:01 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 9,000 | $25.13 | $226,170.00 |
DisclosureSEC source: 0001437749-23-002930 · rdgdoc.xml · nonDerivative · entry 4 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,265 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.25, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 00:01 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionCommon Stock | 9,000 | $2.06 | $18,540.00 |
DisclosureSEC source: 0001437749-23-002930 · rdgdoc.xml · nonDerivative · entry 3 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,265 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2023 Filed Feb 10, 2023 00:01 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-23-002930 · rdgdoc.xml · derivative · entry 5 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,000 Underlying: Common Stock · 1,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Exercisable to the extent of 1/4th thereof on 5/4/16, and remaining balance exercisable to the extent of 1/36th thereof on the 4th day of each month commencing on 6/4/16. Read SEC document |
| February 07, 2023 Filed Feb 10, 2023 00:01 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 1,000 | $25.29 | $25,290.00 |
DisclosureSEC source: 0001437749-23-002930 · rdgdoc.xml · nonDerivative · entry 2 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,265 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022. Read SEC document |
| February 07, 2023 Filed Feb 10, 2023 00:01 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionCommon Stock | 1,000 | $2.06 | $2,060.00 |
DisclosureSEC source: 0001437749-23-002930 · rdgdoc.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,265 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2023 Filed Feb 4, 2023 00:15 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-23-002521 · rdgdoc.xml · derivative · entry 8 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| February 02, 2023 Filed Feb 4, 2023 00:15 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 9,000 | $24.95 | $224,550.00 |
DisclosureSEC source: 0001437749-23-002521 · rdgdoc.xml · nonDerivative · entry 6 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,765 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 15, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.53 to $25.35, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 02, 2023 Filed Feb 4, 2023 00:15 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 9,000 | $2.06 | $18,540.00 |
DisclosureSEC source: 0001437749-23-002521 · rdgdoc.xml · nonDerivative · entry 5 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2023 Filed Feb 4, 2023 00:15 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 1,000 | $23.91 | $23,910.00 |
DisclosureSEC source: 0001437749-23-002521 · rdgdoc.xml · nonDerivative · entry 4 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,765 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 15, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.74 to $24.07, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 02, 2023 Filed Feb 4, 2023 00:15 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 1,000 | $2.06 | $2,060.00 |
DisclosureSEC source: 0001437749-23-002521 · rdgdoc.xml · nonDerivative · entry 3 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2023 Filed Feb 4, 2023 00:15 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-23-002521 · rdgdoc.xml · derivative · entry 7 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| February 01, 2023 Filed Feb 4, 2023 00:15 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 10,000 | $22.87 | $228,700.00 |
DisclosureSEC source: 0001437749-23-002521 · rdgdoc.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,765 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.63 to $23.24, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 01, 2023 Filed Feb 4, 2023 00:15 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $2.06 | $20,600.00 |
DisclosureSEC source: 0001437749-23-002521 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2023 Filed Jan 26, 2023 00:00 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 1,000 | $25.02 | $25,020.00 |
DisclosureSEC source: 0001437749-23-001797 · rdgdoc.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,437 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.01 to $25.02, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 23, 2023 Filed Jan 26, 2023 00:00 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-23-001796 · rdgdoc.xml · derivative · entry 3 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 3,500 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Exercisable to the extent of 1/4th thereof on 5/4/16, and remaining balance exercisable to the extent of 1/36th thereof on the 4th day of each month commencing on 6/4/16. Read SEC document |
| January 23, 2023 Filed Jan 26, 2023 00:00 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 3,500 | $25.01 | $87,535.00 |
DisclosureSEC source: 0001437749-23-001796 · rdgdoc.xml · nonDerivative · entry 2 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,265 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.02, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 23, 2023 Filed Jan 26, 2023 00:00 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionCommon Stock | 3,500 | $2.06 | $7,210.00 |
DisclosureSEC source: 0001437749-23-001796 · rdgdoc.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 19, 2023 Filed Jan 21, 2023 00:24 UTC |
Aebersold SarahChief Human Resources Officer
|
SaleCommon Stock | 374 | $22.93 | $8,575.82 |
DisclosureSEC source: 0001437749-23-001487 · rdgdoc.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,167 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 19, 2023 Filed Jan 21, 2023 00:24 UTC |
DE GREEF RODERICKDirector
|
SaleCommon Stock | 3,801 | $23.19 | $88,145.19 |
DisclosureSEC source: 0001437749-23-001486 · rdgdoc.xml · nonDerivative · entry 1 DE GREEF RODERICK · CIK 0001241181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,160 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 19, 2023 Filed Jan 21, 2023 00:23 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 538 | $22.93 | $12,336.34 |
DisclosureSEC source: 0001437749-23-001484 · rdgdoc.xml · nonDerivative · entry 2 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,437 F3 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 19, 2023 Filed Jan 25, 2023 00:00 UTC Amendment |
DE GREEF RODERICKDirector
|
SaleCommon Stock | 3,801 | $23.19 | $88,145.19 |
DisclosureSEC source: 0001437749-23-001698 · rdgdoc.xml · nonDerivative · entry 1 DE GREEF RODERICK · CIK 0001241181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,160 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 18, 2023 Filed Jan 21, 2023 00:23 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,500 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-23-001485 · rdgdoc.xml · derivative · entry 3 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,500 Underlying: Common Stock · 6,500 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Exercisable to the extent of 1/4th thereof on 5/4/16, and remaining balance exercisable to the extent of 1/36th thereof on the 4th day of each month commencing on 6/4/16. Read SEC document |
| January 18, 2023 Filed Jan 21, 2023 00:23 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 6,500 | $25.04 | $162,760.00 |
DisclosureSEC source: 0001437749-23-001485 · rdgdoc.xml · nonDerivative · entry 2 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,265 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.10, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 18, 2023 Filed Jan 21, 2023 00:23 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionCommon Stock | 6,500 | $2.06 | $13,390.00 |
DisclosureSEC source: 0001437749-23-001485 · rdgdoc.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2023 Filed Jan 21, 2023 00:23 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 3,000 | $25.04 | $75,120.00 |
DisclosureSEC source: 0001437749-23-001484 · rdgdoc.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,975 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.10, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 11, 2023 Filed Jan 13, 2023 00:00 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 258 | $21.94 | $5,660.52 |
DisclosureSEC source: 0001437749-23-000970 · rdgdoc.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,975 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 02:08 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-23-000587 · rdgdoc.xml · derivative · entry 10 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 02:08 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 9,500 | $18.49 | $175,655.00 |
DisclosureSEC source: 0001437749-23-000587 · rdgdoc.xml · nonDerivative · entry 8 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,826 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 15, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.97 to $18.75, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 02:08 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 9,500 | $2.06 | $19,570.00 |
DisclosureSEC source: 0001437749-23-000587 · rdgdoc.xml · nonDerivative · entry 7 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 02:08 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 500 | $17.71 | $8,855.00 |
DisclosureSEC source: 0001437749-23-000587 · rdgdoc.xml · nonDerivative · entry 6 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,826 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 15, 2022. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 02:08 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 500 | $2.06 | $1,030.00 |
DisclosureSEC source: 0001437749-23-000587 · rdgdoc.xml · nonDerivative · entry 5 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2023 Filed Jan 19, 2023 00:01 UTC |
DE GREEF RODERICKDirector
|
GrantCommon Stock | 9,647 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-001269 · rdgdoc.xml · nonDerivative · entry 1 DE GREEF RODERICK · CIK 0001241181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,961 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the "Plan") and fully vests on the first anniversary of the grant date. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:08 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-23-000587 · rdgdoc.xml · derivative · entry 9 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:08 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 500 | $18.81 | $9,405.00 |
DisclosureSEC source: 0001437749-23-000587 · rdgdoc.xml · nonDerivative · entry 4 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,826 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 15, 2022. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:08 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 500 | $2.06 | $1,030.00 |
DisclosureSEC source: 0001437749-23-000587 · rdgdoc.xml · nonDerivative · entry 3 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:08 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 9,500 | $17.72 | $168,340.00 |
DisclosureSEC source: 0001437749-23-000587 · rdgdoc.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,826 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.52 to $17.89, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:08 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 9,500 | $2.06 | $19,570.00 |
DisclosureSEC source: 0001437749-23-000587 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2023 Filed Jan 11, 2023 00:02 UTC |
Aebersold SarahVP, Global Human Resources
|
GrantRestricted Stock Award · Derivative | 12,450 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-000821 · rdgdoc.xml · derivative · entry 2 Aebersold Sarah · CIK 0001837756 · VP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,450 Underlying: Common Stock · 12,450 shares Expires not disclosed F2 · shares: The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in Column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2023 through December 31, 2024 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period. F2 · derivative.exercise_date: The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in Column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2023 through December 31, 2024 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period. F2 · derivative.expiration_date: The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in Column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2023 through December 31, 2024 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period. Read SEC document |
| January 03, 2023 Filed Jan 11, 2023 00:02 UTC |
Aebersold SarahVP, Global Human Resources
|
GrantCommon Stock | 12,450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-000821 · rdgdoc.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · VP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,541 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the "Plan") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2023 compensation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.